wouldn’t over - interpret the results, you’re comparing 14 patients here vs a study 30x the size, it only takes one to go the other way and with such a small sample the % response won’t look so good. Best we can say is it’s met its objective of finding a dose to take into the next phase and initial response rates are ok.
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-21
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
